Commentary

0
0
0
s2smodern

 Clive Bates | 19 June 2013

So the MHRA will regulate e-cigarettes as though they are medicines – press release . 10 reasons why is this a bad idea.

 

0
0
0
s2smodern

 Clive Bates | 9 June 2013

Time to discuss the ‘gateway effect’… the idea that e-cigarettes or snus (a form of low risk smokeless tobacco) might be a cause of children taking up high risk cigarette smoking that would not otherwise happen. There’s virtually nothing in this theory – it is largely a campaigning tactic. But you hear much less about the genuine beneficial gateway effects that lead kids away from smoking. As my friend David Sweanor puts it:

beware the unintended consequences of our fear of unintended consequences

David Sweanor

0
0
0
s2smodern

 Clive Bates | 23 May 2013

When the UK Medicines Regulator (MHRA) consulted in 2010 on whether e-cigarettes should be regulated as medicines, it gave three options: I summarise the first two and quote the third:
Option 1 . Regulate as medicines and withdraw unlicensed products in 21 days
Option 2 . Regulate as medicines and withdraw unlicensed products in a year (June 2011)
Option 3 . “ Do nothing and allow these unregulated products containing nicotine that have not been assessed for safety, quality and efficacy to remain on the market .” [emphasis mine]

0
0
0
s2smodern

 Gerry Stimson | 23 May 2013

In a letter to MEPs on the EU Parliament ENVI Committee, regarding the proposed regulation of electronic cigarettes in the draft Tobacco Products Directive, Professor Gerry Stimson makes the case for ‘twin-track’ regulation

April 22, 2013

Dear Member,

I am writing to you concerning the draft Tobacco Products Directive and in particular Article 18 which seeks to regulate nicotine containing products (NCP) - including electronic cigarettes - as medicinal products.